medical-conditions Diabetes patients demonstrate reduced bone density, as revealed by 3D DEXA scans , and Administrator 2025 September 14
medical-conditions AI prioritizes connection with patients instead of solely focusing on generating reports , and Administrator 2025 September 14
medical-conditions Rising Utilization of Pets for Detecting Infections in Cardiac Devices , and Administrator 2025 September 14
medical-conditions Tenant's persistent antisocial actions lead to evacuation, as determined by the Ombudsman , and Administrator 2025 September 14
medical-conditions Daily intake of diet soda allegedly accelerates brain aging at a faster rate than previously assumed, according to recent research. , and Administrator 2025 September 14
Science Trump praises Florida's decision to scrap vaccine requirements, asserting that the existing vaccines are effective, referring to it as a firm stance. , and Administrator 2025 September 14
Science Competing with Garmin, Amazfit's latest T-Rex 3 Pro sports watch showcases numerous cutting-edge features and enhanced GPS capabilities. , and Administrator 2025 September 14
Science Jen Aniston-Endorsed Low-Impact Functional Fitness Regime, Pvolve, Tested: My Personal Insights , and Administrator 2025 September 14
Science Introducing a new viral fitness challenge: 75 Hotter, surpassing the popularity of 75 Hard. Dive into the details of this intriguing workout regimen that users can't seem to resist. , and Administrator 2025 September 14
Science Directive Proposal Request for Safeguarding Youth in Case of Accidents by the Commission , and Administrator 2025 September 14
medical-conditions Cancer-Related Exhaustion and the Role of Qigong in Alleviation , and Administrator 2025 September 14
Science Fear of Fish: Comprehensive Information on Signs, Roots, and Beyond , and Administrator 2025 September 14
medical-conditions Cannabis Use and Attention Deficit Hyperactivity Disorder: Advantages, Drawbacks, and Further Information , and Administrator 2025 September 14
medical-conditions Global phase III trial commences for Zilebesiran, a drug developed by Genentech and Alnylam, in the worldwide population experiencing uncontrolled hypertension to evaluate its impact on cardiovascular outcomes. , and Administrator 2025 September 14
medical-conditions InMed to Attend the 27th Annual Global Investment Conference Hosted by H.C. Wainwright , and Administrator 2025 September 14
